Zubareva, E. Y., Senchukova, M. A., Virich, E. V., Zubarev, M. R., & Goncharova, M. A. (2021). Serum HIF-1α and TGF-β1 levels depending on the clinical and morphological characteristics of breast cancer and sensitivity of tumor to neoadjuvant chemotherapy. QUASAR, LLC.
Chicago Style (17th ed.) CitationZubareva, E. Yu., M. A. Senchukova, E. V. Virich, M. R. Zubarev, and M. A. Goncharova. Serum HIF-1α and TGF-β1 Levels Depending on the Clinical and Morphological Characteristics of Breast Cancer and Sensitivity of Tumor to Neoadjuvant Chemotherapy. QUASAR, LLC, 2021.
MLA (9th ed.) CitationZubareva, E. Yu., et al. Serum HIF-1α and TGF-β1 Levels Depending on the Clinical and Morphological Characteristics of Breast Cancer and Sensitivity of Tumor to Neoadjuvant Chemotherapy. QUASAR, LLC, 2021.